Condition: Patent Foramen Ovale · Cryptogenic Stroke · Sponsor: Encore Medical Inc.
The objective of this study is to establish reasonable assurance of safety, effectiveness, and noninferiority of the Encore PFO closure device when compared to any investigator chosen FDA-approved PFO closure device.
This description comes directly from the study's public registry record.
Joseph Marino · 651-797-0913 · jmarino@encore-medical.com
Hannah Bearinger · hannah.bearinger@brightresearch.com
Always discuss trial participation with your own doctor first.
| Arkansas Cardiology | Little Rock, Arkansas, United States | Recruiting |
| Southern CA Permanente Medical Group - Kaiser San Diego and Scripps Memorial Hospital | La Jolla, California, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Mercy One Iowa Heart Center | West Des Moines, Iowa, United States | Recruiting |
| Kansas University Medical Center | Kansas City, Kansas, United States | Recruiting |
| Jackson Heart Clinic | Jackson, Mississippi, United States | Recruiting |
| CHI Health | Omaha, Nebraska, United States | Recruiting |
| Medical University of South Carolina Gazes Research Institute | Charleston, South Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05537753